Premium
Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line
Author(s) -
Gu Yixue,
Fan Shasha,
Xiong Yan,
Peng Bo,
Zheng Guopei,
Yu Yanhui,
Ouyang Yongmei,
He Zhimin
Publication year - 2011
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2010.12.045
Subject(s) - cisplatin , gene , biology , gene expression , microbiology and biotechnology , microarray analysis techniques , microarray , cell culture , cancer research , drug resistance , apoptosis , genetics , chemotherapy
To explore the mechanisms of chemotherapy resistance, we previously established a multi‐drug resistant cell line, Tca8113/Pingyangmycin (Tca8113/PYM) and identified differential expression in known genes and ESTs using microarray analysis. From among those ESTs we have now identified a novel gene producing an mRNA of 1834 nucleotides translated into a protein having 235 amino acids. This gene was denominated as tongue cancer resistance‐associated protein 1 gene ( TCRP1 , accession number: EF363480 ). We further determined its functional characteristics. The results demonstrate that TCRP1 mediates a specific resistance to cisplatin in Tca8113 cells by reducing the cisplatin‐induced apoptosis. This suggests that TCRP1 might be a novel molecular target to develop agents to reverse cisplatin‐induced chemoresistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom